Artificial Intelligence

Artificial intelligence, or AI, is an umbrella term for machine learning and deep learning. It is where a machine takes in information from its surroundings and, from that, makes the most optimal decision appropriate to the situation.

AI in Food: How Artificial Intelligence is Designing Healthier and More Sustainable Foods

Artificial intelligence is transforming food innovation by accelerating ingredient discovery, optimizing formulations, and enabling personalized nutrition strategies to improve public health outcomes. AI-driven tools also support food safety assessment, sustainable food systems, and precision nutrition while raising important governance, equity, and validation challenges.

Machine Learning in Drug Development

Deep-Learning in Radiology

Can Artificial Intelligence be used to Diagnose Brain Aneurysms?

The Role of AI in Pathogen Detection and Epidemic Prediction

AI-Powered Genomic Analysis: Revolutionizing the Detection of Genetic Mutations

Recent Developments in Health Technology

The Pros and Cons of Healthcare Chatbots

Artificial Intelligence in Cardiology

Artificial Intelligence and Life Science

Artificial Intelligence in CBT

Artificial Intelligence and Deep Learning in Medicine

See more featured articles »

AI Psychosis: How Artificial Intelligence May Trigger Delusions and Paranoia

What does ChatGPT mean for Healthcare?

Is Data at the Center of Healthcare for the Future?

Managing the Explosion of Healthcare Data to Harness its Power

Applying Deep Learning to Localization Microscopy

Artificial Intelligence in Histopathology

How Artificial Intelligence Is Revolutionizing Emergency Medicine

The Medical Industries That Are Most Likely to Be Impacted by Ai

Uncovering the Mystery of the Human Brain with Computational Neuroscience

Beyond Virtual Consultations: The Rise of AI-Driven Virtual Healthcare Assistants

Ethical Considerations in AI-Driven Healthcare

Latest Artificial Intelligence News and Research

Machine learning model filters out the biological noise in liquid biopsy samples

A machine learning model developed by researchers at the Johns Hopkins Kimmel Cancer Center filters out the biological noise in liquid biopsy samples, helping clinicians better match therapies to their patients' tumors.

9 Jun 2026

Radiology AI systems flag breast cancer signs six years before diagnosis

Three commercially available radiology AI systems have shown the potential to flag early signs of breast cancer up to 6 years before a diagnosis, according to a study published in Radiology, the flagship journal of the Radiological Society of North America (RSNA).

9 Jun 2026

New study frames altered protein modifications as cancer drivers

Cancer has often been explained through mutations in deoxyribonucleic acid (DNA) or changes in ribonucleic acid (RNA), but these layers do not fully explain why tumors with similar genetic profiles can behave differently.

9 Jun 2026

Large study uncovers brain network differences in bipolar disorder

New research from the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC has discovered subtle but widespread differences in the brain's communication networks in people with bipolar disorder, offering new insight into how illness severity and treatment may relate to brain wiring.

9 Jun 2026

AI screening tool increases diabetic eye exam referrals for African Americans

In a study exploring how an AI-assisted diagnostic tool shaped care for underserved populations at multiple community-based primary care sites, investigators at the Wilmer Eye Institute, Johns Hopkins Medicine found that African American patients with diabetes were more likely to receive a diabetic eye exam referral if screened by an AI tool.

9 Jun 2026

Common joint supplement may accelerate Alzheimer's disease progression

New research has found an association between taking glucosamine, a popular over-the-counter supplement used for joint pain, and a higher likelihood of progressing from mild cognitive impairment to Alzheimer's disease.

9 Jun 2026

New non-invasive tool lowers cancer DNA tracking threshold to 5%

Blood tests have proved to be a promising tool for detecting and monitoring cancer. Researchers at Chalmers University of Technology and the University of Gothenburg, Sweden, have now developed a new method that makes it possible to analyze samples containing as little as 5 per cent cancer DNA in the blood, compared with the 15–20 per cent required today. This method could lead to better cancer care and improved monitoring of tumor progression.

9 Jun 2026

AI-designed molecular switch uses caffeine to control engineered cells

For many of us, a warm cup of coffee is how we start our day. For Texas A&M Health researchers, it may also offer a new way to control engineered cells in future medicines.

8 Jun 2026

AI predicts meningioma recurrence from routine pathology slides

Mayo Clinic researchers and collaborators have shown that artificial intelligence (AI) can analyze routine pathology slides to help classify meningiomas, the most common primary brain tumor in adults, and predict a patient's risk of tumor recurrence.

7 Jun 2026

Researchers identify hidden self-harm histories using machine learning

Important mental health history is often present in medical records but hard to find, especially when it is missing from the diagnosis codes that clinicians, researchers and health systems use to search and count conditions.

5 Jun 2026

Novel artificial intelligence technology improves eye disease diagnosis

Non-invasive eye scans allow doctors a zoomed-in, three-dimensional look beneath the eye's surface without causing discomfort or pain to the patient.

5 Jun 2026

Revolutionizing calibration: How Lumo uses machine learning to streamline E&L screening and toxicological risk assessment

Lumo leverages advanced machine learning to reduce calibration time, and flag low-confidence response factor predictions.

From Jordi Labs 5 Jun 2026

Universal Sarbeco coronavirus vaccine proves safe in first human trial

The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no significant side-effects.

4 Jun 2026

Blood protein signature can predict lung cancer risk before diagnosis

Researchers at the Francis Crick Institute and University College London (UCL), funded by Cancer Research UK and the European Research Council (ERC), have identified a 14-protein signature in the blood that can predict lung cancer risk more than five years before diagnosis.

4 Jun 2026

AI detects early warning signs of epilepsy without visible seizures

Epilepsy isn't always easy to diagnose. Seizures often don't occur during routine brain-wave recordings (EEGs), leaving doctors without the direct observation they need to make a clear diagnosis.

4 Jun 2026

New BioCoach AI provides real-time biomechanical feedback for exercises

As any athlete will tell you: perfect practice makes perfect. But for individuals who do not have regular access to coaches or trainers, maintaining good form can be tricky.

4 Jun 2026

Brain remodeling bypasses the prefrontal bottleneck to automate complex skills

New research by Georgetown scientists shows how the brain rewires itself to automate learned tasks. The findings challenge a long-held understanding of how humans master complex skills, suggesting that true multitasking is really possible.

4 Jun 2026

Patented technology enables real-time detection of surgical bleeding sources

The United States Patent and Trademark Office (USPTO) officially issued a new patent to Wayne State University and RediMinds Inc. of Southfield, Michigan. The patent protects a pioneering technological advancement developed in the university's laboratories.

3 Jun 2026

Study potentially opens a new route to more selective cancer drug design

Researchers at the Icahn School of Medicine at Mount Sinai have identified a previously hidden druggable site in a cancer-related protein that could open the door toward the development of a new generation of more precise cancer drugs.

3 Jun 2026